Patent · US Active

Macrocyclic toll-like receptor 7 (TLR7) agonists

US11485741B2 · kind B2 · utility

0Cited by

18References

18Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Ashok Vinayak Purandare · Pennington, US
Honghe Wan · Pennington, US
Liqi He · West Chester, US
Sanjeev Gangwar · Foster City, US
Shoshana L. Posy · Highland Park, US
Yam B. Poudel · Fremont, US
Prasanna Sivaprakasam · Lawrenceville, US
Naidu S. Chowdari · Sunnyvale, US

Key dates

Filing date	Apr 23, 2019
Grant date	Nov 1, 2022
Priority date	—
Expiry date	Apr 23, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/60
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds having a structure according to formula are modulators of TLR7 activity and can be used to treat conditions amenable to treatment by the modulation of TLR7 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.